Drug Type Small molecule drug |
Synonyms PXS 5338K, PXS-5338K |
Target |
Action inhibitors |
Mechanism LOXL2 inhibitors(Lysyl oxidase homolog 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Idiopathic Pulmonary Fibrosis | Phase 1 | Australia | 14 Dec 2017 | |
| Liver Cirrhosis | Phase 1 | - | - | |
| Nonalcoholic Steatohepatitis | Phase 1 | Australia | - | |
| Pulmonary Fibrosis | Phase 1 | - | - | |
| Renal fibrosis | Phase 1 | - | - | |
| Neoplasms | Preclinical | Australia | - |





